Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 21, 2024; 30(11): 1545-1555
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1545
Published online Mar 21, 2024. doi: 10.3748/wjg.v30.i11.1545
Figure 1 Study design.
AN-PEP: Aspergillus niger prolyl endopeptidase protease; CSI: Celiac symptom index; GIP: Gluten immunogenic peptides; SF-36: Short Form-36 health survey questionnaire.
Figure 2 Flowchart of enrolled patients.
AN-PEP: Aspergillus niger prolyl endopeptidase protease.
- Citation: Stefanolo JP, Segura V, Grizzuti M, Heredia A, Comino I, Costa AF, Puebla R, Temprano MP, Niveloni SI, de Diego G, Oregui ME, Smecuol EG, de Marzi MC, Verdú EF, Sousa C, Bai JC. Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet. World J Gastroenterol 2024; 30(11): 1545-1555
- URL: https://www.wjgnet.com/1007-9327/full/v30/i11/1545.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i11.1545